Ifosfamide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ifosfamide Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jun 12, 2026. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0143-9530-01
- Dosage Form
- Injection
- Presentation
- Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)
- Initial Posting
- Jun 12, 2026
Reason
Demand increase for the drug